Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease

Study Overview
=================
Brief Summary
-----------------
The aim of this study is to adjust and test an existing internet-based tool for collecting patient-reported outcome measures and to use the internet-based tool in an multidisciplinary follow-up of patients treated for malignant hematological diseases. The patient-reported outcome measurements will be used in describing the patients' health-related quality of life (HRQoL) and to investigate whether the HRQol will increase due to participation in multidisciplinary follow-up.

Official Title
-----------------
Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease; Focus on the Patient's Preferences and Life Situation

Conditions
-----------------
Malignant Hematologic Neoplasm

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: patients diagnosed with malignant hematological disease; Morbus Hodgkin and B- and T-cell disease patients followed before or after 1. line treatment patients in stable phase > 6 months after 1. line treatment the patients participation in the study must be assessed and decided by the doctor responsible for the patient's course of treatment Exclusion Criteria: Health conditions which demands close medical monitoring conditions which compromise the ability to understand the study and submit informed consent (ex.: dementia and severe mental illness / disability) lack of capability to fill out electronic questionnaires poor self-care and/or compliance

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Health-Related Quality of Life (HRQoL) - General | Patients will be asked to electronically fill out questionnaires before each consultation. The questionnaire that will be used to measure HRQoL is SF-36. SF-36 is a generic questionnaire which can be used to assess HRQoL in the general public. | HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months. | 
| Health-Related Quality of Life (HRQoL) - Disease specific | Patients will be asked to electronically fill out questionnaires before each consultation. The questionnaire that will be used to measure HRQoL is EORTC C30 QLQ. EORTC C30 QLQ is a disease specific questionnaire which can be used to assess HRQoL in patients diagnosed with cancer | HRQoL is assessed every 2, 3, 4 or 6 months, up to 18 months. | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Symptoms of depression and anxiety | Data on symptoms of depression and anxiety will be collected before and after each consultation using an international validated questionnaire. The questionnaire which will be used is: Hospital Depression and Anxiety Scale (HADS) | Symptoms of depression and anxiety will be assessed every 2, 3, 4 or 6 month, up to 18 months | 
| Symptoms of hematological disease | Data on symptoms of disease will be collected before each consultation using an international validated questionnaire. The questionnaire which will be used is: Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) | Symptoms of disease will be assessed every 2, 3, 4 or 6 month, up to 18 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Patient-reported outcomes, Health-related QoL, Internet-based tool